The phylogenetic map of your human kinome demonstrating improvement and US FDA approval of smaller molecule kinase inhibitors to tyrosine kinases and serine/threonine kinases for a number of stable and hematologic malignancies. Olumiant (baricitinib) - In June 2018, the FDA to start with approved